Related Experiment Video
Updated: Jun 16, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Lipid II and other bactoprenol-bound cell wall precursors as drug targets
Tanja Schneider1, Hans-Georg Sahl
1University of Bonn, Institute of Medical Microbiology, Immunology and Parasitology, Pharmaceutical Microbiology Section, Meckenheimer Allee 168, 53115 Bonn, Germany.
Abstract:
Bacterial cell wall biosynthesis represents an antibiotic target pathway for therapeutic intervention. An increasing number of natural antibiotic compounds have been demonstrated to inhibit the membrane-associated steps of cell wall biosynthesis by targeting bactoprenol-mediated precursor cycling, particularly at the stage of the completed building block Lipid II. These antibiotic compounds belong to various chemical classes including glycopeptides, lipopeptides and lipodepsipeptides, and lantibiotics and other antimicrobial peptides. The clinical success of vancomycin in the treatment of multiresistant Gram-positive bacteria has stimulated further development of glycopeptide antibiotics and research of other Lipid II-binding compounds. The state-of-the-art in the targeting of cell wall precursors is summarized in this review.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial Cell Wall
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Biosynthesis of Lipids
Peptidoglycan Synthesis
Archaeal Cell Wall

